An Evening with Harry Connick, Jr. and Jill Connick
July 17, 2018
6 - 8 pm
The Cable Center
We are happy that you are interested in attending our event. Please complete the information below and we will respond with a confirmation. Only confirmed registrants will be admitted to the event.
For each registered individual that attends the event, a $5 donation will be given to Colorectal Cancer Alliance, Fight CRC, and The Vince Lombardi Cancer Foundation to support colon cancer research and advocacy.
**Health Care Professionals are considered to be individuals or entities involved in the provision of health care services and/or items to patients, which purchase, lease, recommend, use, arrange for the purchase or lease of, or prescribe Companies’ Medical Technologies in the United States.
***The contest is not eligible for Medicare and state healthcare program beneficiaries.
Having issues with registration? Please email email@example.com with any questions.
Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy. Cologuard is indicated to screen adults of either sex, 50 years or older, who are at typical average-risk for CRC. Cologuard is not for everyone; not for high risk individuals, including those with a history of colorectal cancer and advanced adenoma, IBD and certain hereditary syndromes. Positive Cologuard results should be referred to diagnostic colonoscopy. A negative Cologuard test result does not guarantee absence of cancer or advanced adenoma. Following a negative result, patients should continue participating in a screening program at an interval and with a method appropriate for the individual patient. Cologuard performance when used for repeat testing has not been evaluated or established. Rx only.